NUS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NU Skin Enterprises Inc (NUS) is not a good buy for a beginner investor with a long-term strategy at this time. The financial performance is weak, with significant YoY declines in revenue, net income, and EPS. Technical indicators are neutral, and there are no strong trading signals or positive catalysts to support a buy decision. The options data and trading trends also do not indicate strong sentiment or momentum.
The MACD is slightly positive at 0.0351 but contracting, RSI is neutral at 40.358, and moving averages are converging, indicating no clear trend. The stock is trading near its support level of 7.434, with resistance at 7.961. Overall, the technical indicators suggest a neutral outlook.
Gross margin increased by 12.91% YoY to 70.74%, which is a positive sign for operational efficiency.
No recent news or significant trading trends from hedge funds or insiders. Stock trend analysis predicts a potential decline in the next day, week, and month.
In Q4 2025, the company reported a revenue decline to $370.32M (-16.89% YoY), net income dropped to $14.49M (-140.14% YoY), and EPS fell to 0.29 (-139.73% YoY). However, gross margin improved to 70.74% (+12.91% YoY).
No recent analyst rating or price target changes available.
